TRIM9 and urinary bladder carcinoma: Our results revealed the molecular mechanisms by which TRIM9 facilitates tumor growth, metastasis and chemoresistance in bladder cancer, and provided a promising combined therapy strategy to improve the outcome of chemotherapy.